17β-hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study

BACKGROUND: Approximately 20–40% of patients diagnosed with breast cancer will experience a recurrence up to 20 years after their original diagnosis. 17?-hydroxysteroid dehydrogenase 1 and 2 (HSD17B1 and HSD17B2, respectively) regulate intratumoral concentrations of oestradiol, which promotes growth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Oncol
Hauptverfasser: Collin, Lindsay J, Ulrichsen, Sinna P, Ahern, Thomas P, Goodman, Michael, McCullough, Lauren E, Waller, Lance A, Christensen, Kristina B, Damkier, Per, Hamilton-Dutoit, Stephen, Lauridsen, Kristina L, Yacoub, Rami, Christiansen, Peer M, Ejlertsen, Bent, Sørensen, Henrik Toft, Cronin-Fenton, Deirdre P, Lash, Timothy L
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7033004/
https://ncbi.nlm.nih.gov/pubmed/31671023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0284186X.2019.1684560
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge